ARTICLE | Company News
Cancer Genetics acquires vivoPharm
September 1, 2017 3:05 PM UTC
Cancer Genetics Inc. (NASDAQ:CGIX) acquired preclinical services company vivoPharm Pty. Ltd. (Kent Town, Australia) for about $12.4 million. The transaction includes $1.2 million in cash and 3.1 mi...